Genetic characteristics that influence the risk of Parkinson’s disease (PD) due to pesticide exposure.
SciSparc signs patent license deal with Polyrizon for pain therapy
SciSparc will earn royalties from the commercialisation of the pain therapy. Credit: Wasan Tita/Shutterstock. Israel-based pharmaceutical company SciSparc has signed an exclusive patent licence agreement